臨床試験

Fareon Open Label Device Clinical Trial

NCT: NCT07600320 · NOT_YET_RECRUITING

NCT識別子NCT07600320

ステータスNOT_YET_RECRUITING

開始日2026-05-01

完了2027-04-30

SponsorIcahn School of Medicine at Mount Sinai (OTHER)

First posted2026-05-20

Last updated2026-05-20

概要

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。